Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody


Cat: MO-NAB-00873W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

  • Product List
  • Specifications
  • Application Information
  • Target
Sub Cat Clonality Species Reactivity Application Clone Conjugate Size  
MO-NAB-00873W Monoclonal WB, ELISA NW0796 100 µg
MO-NAB-00891W Monoclonal WB, ELISA NW0814 100 µg
MO-NAB-00893W Monoclonal WB, ELISA NW0816 100 µg
MO-NAB-00896W Monoclonal WB, ELISA NW0819 100 µg
MO-NAB-00899W Monoclonal WB, ELISA NW0822 100 µg
MO-NAB-00901W Monoclonal WB, ELISA NW0824 100 µg
MO-NAB-00911W Monoclonal WB, ELISA NW0834 100 µg
MO-NAB-00912W Monoclonal WB, ELISA NW0835 100 µg

Specifications

Host speciesHuman (Homo sapiens)
Species ReactivitySARS-CoV-2; SARS-COV
CloneNW0796
ImmunogenRecombinant SARS-CoV-2 RBD protein
FormatLiquid or Lyophilized
BufferPBS, pH7.5
StorageStore at 4°C: short-term (1-2weeks)
Store at -20°C: long-term and future use

Application Information

ApplicationWB, ELISA
Application NotesWB: 1:1000-2000
Elisa: 1:5000-1:10000

Target

IntroductionSARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), also known as 2019-nCoV (2019 Novel Coronavirus), is a virus that can cause serious illnesses from the common cold. SARS-CoV-2 Spike protein consists of S1 domain and S2 domain. S1 contains a receptor binding domain (RBD) that specifically binds to the receptor angiotensin converting enzyme 2 (ACE2) on target cells. It is believed that the SARS-CoV-2 spike protein (RBD) has potential value for the diagnosis of the virus.
Product OverviewRecombinant anti-SARS-CoV-2 RBD antibody is expressed from XtenCHO
Alternative NamesSpike glycoprotein; 2019-nCov RBD Protein; 2019-nCoV Spike RBD Protein
UniProt ID
For Research Use Only | Not For Clinical Use.
Online Inquiry